Leslie W. Kreis - Director, 10%+ Owner at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Leslie W. Kreis - trading volume in the past year for Actuate Therapeutics, Inc.

Holdings reported by Leslie W. Kreis for Actuate Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.51M $23.1M $9.21 Jun 27, 2025 Directly held by Bios Fund III QP, LP
Common Stock 2.09M $19.3M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest II, LP
Common Stock 1.26M $11.6M $9.21 Jun 27, 2025 Directly held by Bios Clinical Opportunity Fund, LP
Common Stock 980K $9.03M $9.21 Jun 27, 2025 Directly held by Bios Fund II QP, LP
Common Stock 573K $5.28M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest III, LP
Common Stock 526K $4.84M $9.21 Jun 27, 2025 Directly held by Bios Fund I, LP
Common Stock 405K $3.73M $9.21 Jun 27, 2025 Directly held by Bios Fund III NT, LP
Common Stock 384K $3.53M $9.21 Jun 27, 2025 Directly held by Bios Fund III, LP
Common Stock 308K $2.83M $9.21 Jun 27, 2025 Directly held by Bios Fund I QP, LP
Common Stock 301K $2.77M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest I, LP
Common Stock 300K $2.76M $9.21 Jun 27, 2025 Directly held by Bios Fund II, LP
Common Stock 196K $1.37M $7.00 Jun 27, 2025 Directly held by Bios 2024 Co-Invest, LP
Common Stock 131K $1.21M $9.21 Jun 27, 2025 Directly held by Bios Fund II NT, LP
Common Stock 84.9K $782K $9.21 Jun 27, 2025 Directly held by BP Directors, LP
Common Stock 69.4K $639K $9.21 Jun 27, 2025 Directly held by Circle K Invesco, LP
Common Stock 61K $562K $9.21 Jun 27, 2025 Directly held by Aaron G.L. Fletcher
Common Stock 8.06K $74.2K $9.21 Jun 27, 2025 Directly held by KF Legacy Trust U/A/D December 7, 2016
Common Stock 8.06K $74.2K $9.21 Jun 27, 2025 Directly held by MF Legacy Trust U/A/D December 7, 2016
Warrant (Right to Buy) 71.4K Jun 27, 2025 Directly held by Bios 2024 Co-Invest, LP Common Stock
Stock Options 31.9K Aug 12, 2024 Directly held by BP Directors, LP Common Stock 31.9K
Stock Options 15K Aug 12, 2024 Directly held by Aaron G.L. Fletcher Common Stock
Convertible Note 0 Aug 14, 2024 Directly held by Bios Clinical Opportunity Fund, LP Common Stock
Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I, LP Common Stock
Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I QP, LP Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest II, LP Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest III, LP Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP Common Stock
Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II, LP Common Stock
Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP Common Stock
Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP Common Stock

Transactions reported by Leslie W. Kreis for Actuate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.